The Recall Genie:
Time to Go Back in the Bottle
DAVID NEWMAN,
EUGENE CRYSTAL,
BERNARD GOLDMAN,
DAVID NEWMAN
Divisions of Cardiology and Cardiac Surgery, University of Toronto, Toronto, Canada
Search for more papers by this authorEUGENE CRYSTAL
Divisions of Cardiology and Cardiac Surgery, University of Toronto, Toronto, Canada
Search for more papers by this authorBERNARD GOLDMAN
Divisions of Cardiology and Cardiac Surgery, University of Toronto, Toronto, Canada
Search for more papers by this authorDAVID NEWMAN,
EUGENE CRYSTAL,
BERNARD GOLDMAN,
DAVID NEWMAN
Divisions of Cardiology and Cardiac Surgery, University of Toronto, Toronto, Canada
Search for more papers by this authorEUGENE CRYSTAL
Divisions of Cardiology and Cardiac Surgery, University of Toronto, Toronto, Canada
Search for more papers by this authorBERNARD GOLDMAN
Divisions of Cardiology and Cardiac Surgery, University of Toronto, Toronto, Canada
Search for more papers by this authorAddress for reprints: Bernard Goldman, M.D., H405, 2075 Bayview Ave., Toronto, Ontario, Canada, M4N 3M5. E-mail: [email protected]
No abstract is available for this article.
References
- 1 Kawanishi DT, Song S, Furman S, et al. Failure rates of leads, pulse generators, and programmers have not diminished over the last 20 years: Formal monitoring of performance is still needed. BILITCH Registry and STIMAREC. PACE 1996; 19: 1819–1823.
- 2 Maisel WH, Sweeney MO, Stevenson WG, et al. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA 2001; 286: 793–799.
- 3 Goldman BS, Newman D, Fraser J, et al. Management of intracardiac device recalls: a consensus conference. Participants of the Consensus Conference. North American Society of Cardiac Pacing and Electrophysiology (NASPE). PACE 1996; 19: 7–17.
- 4 Schoenfeld MH. Recommendations for implementation of a North American Multicenter Arrhythmia Device/Lead Database. PACE 1992; 15: 1632–1636.
- 5 Tang ASL GM, Connolly SJ, Kerr C, et al. Effect of pacemaker dependency on the benefit of physiologic over ventricular pacing. Circulation 1999.
- 6 Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107: 2932–2937.
- 7 Crick JC, Rokas S, Sowton E. Identification of pacemaker dependent patients by serial decremental rate inhibition. Eur Heart J 1985; 6: 891–896.
- 8 Nanthakumar K, Dorian P, Ham M. et al. When pacemakers fail: An analysis of clinical presentation and risk in 120 patients with failed devices. PACE 1998; 21: 87–93.
- 9 Bokhari F, Newman D, Korley V, et al. Implantable cardioverter defibrillator vs. amiodarone: Eleven years follow up of the Canadian Implantable Defibrillator Study. (abstract) Circulation 2002; 106: 497.
- 10 Moss AJ, Zareba W, Hall WJ, et al., and the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–883.
- 11 Geist M, Newman D, Greene M, et al. Permanent explantation of implantable cardioverter defibrillators. PACE 2000; 23: 2024–2029.
- 12 Kay GN, Brinker JA, Kawanishi DT, et al. Risks of spontaneous injury and extraction of an active fixation pacemaker lead: Report of the Accufix Multicenter Clinical Study and Worldwide Registry. Circulation 1999; 100: 2344–2352.
Citing Literature
